Cargando…
Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome
Individuals who have Down syndrome (trisomy 21) are at greatly increased risk of developing Alzheimer’s disease, characterised by the accumulation in the brain of amyloid-β plaques. Amyloid-β is a product of the processing of the amyloid precursor protein, encoded by the APP gene on chromosome 21. I...
Autores principales: | Cannavo, Claudia, Cleverley, Karen, Maduro, Cheryl, Mumford, Paige, Moulding, Dale, Fisher, Elizabeth M. C., Wiseman, Frances K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094519/ https://www.ncbi.nlm.nih.gov/pubmed/35544526 http://dx.doi.org/10.1371/journal.pone.0262558 |
Ejemplares similares
-
Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models
por: Tosh, Justin L., et al.
Publicado: (2021) -
Publisher Correction: Genetic dissection of down syndrome‑associated alterations in APP/amyloid‑β biology using mouse models
por: Tosh, Justin L., et al.
Publicado: (2021) -
Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B
por: Wu, Yixing, et al.
Publicado: (2023) -
Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches
por: Farrell, Clíona, et al.
Publicado: (2022) -
A novel knockout mouse for the small EDRK-rich factor 2 (Serf2) showing developmental and other deficits
por: Cleverley, Karen, et al.
Publicado: (2021)